These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30348839)

  • 1. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.
    Siriwardena SU; Perera MLW; Senevirathne V; Stewart J; Bhagwat AS
    Mol Cell Biol; 2019 Jan; 39(1):. PubMed ID: 30348839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of uracils created by APOBEC3A using UdgX shows colocalization with RPA at stalled replication forks.
    Stewart JA; Schauer G; Bhagwat AS
    Nucleic Acids Res; 2020 Nov; 48(20):e118. PubMed ID: 33074285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
    Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
    Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
    Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
    Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
    J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
    Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
    PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.
    Auerbach AA; Becker JT; Moraes SN; Moghadasi SA; Duda JM; Salamango DJ; Harris RS
    mSphere; 2022 Dec; 7(6):e0045122. PubMed ID: 36374108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
    Buisson R; Lawrence MS; Benes CH; Zou L
    Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3B: pathological consequences of an innate immune DNA mutator.
    Burns MB; Leonard B; Harris RS
    Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3B is an enzymatic source of mutation in breast cancer.
    Burns MB; Lackey L; Carpenter MA; Rathore A; Land AM; Leonard B; Refsland EW; Kotandeniya D; Tretyakova N; Nikas JB; Yee D; Temiz NA; Donohue DE; McDougle RM; Brown WL; Law EK; Harris RS
    Nature; 2013 Feb; 494(7437):366-70. PubMed ID: 23389445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
    Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
    Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring APOBEC3A protein levels in human cancer cells.
    Dananberg A; Maciejowski J
    Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
    Vural S; Simon R; Krushkal J
    Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.
    Shi K; Carpenter MA; Banerjee S; Shaban NM; Kurahashi K; Salamango DJ; McCann JL; Starrett GJ; Duffy JV; Demir Ö; Amaro RE; Harki DA; Harris RS; Aihara H
    Nat Struct Mol Biol; 2017 Feb; 24(2):131-139. PubMed ID: 27991903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMCES Maintains Replication Fork Progression and Prevents Double-Strand Breaks in Response to APOBEC Deamination and Abasic Site Formation.
    Mehta KPM; Lovejoy CA; Zhao R; Heintzman DR; Cortez D
    Cell Rep; 2020 Jun; 31(9):107705. PubMed ID: 32492421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes.
    Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo.
    Naumann JA; Argyris PP; Carpenter MA; Gupta HB; Chen Y; Temiz NA; Zhou Y; Durfee C; Proehl J; Koniar BL; Conticello SG; Largaespada DA; Brown WL; Aihara H; Vogel RI; Harris RS
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.